The News Review:

- Community Participation Key to Improving Medical Research
- Whiteside awards research grants
- Enzo Biochem Names Kevin Krenitsky President of Enzo Clinical Labs
- » Clinical Research Associate

Community Participation Key to Improving Medical Research
University of Rochester Newsroom
edu) helps potential volunteers understand the importance and basics of clinical trials learn how to participate in research search a database of studies that are currently enrolling volunteers and addresses issues such as safety time commitment and compensation. URMC is also running a series of prints ads designed to raise public awareness regarding medical research and direct people to the new website. The campaign is a part of a broader effort underway at the School of Medicine and Dentistry (SMD) to re-engineer clinical research in a manner that translates science more quickly into new ways to understand treat and prevent disease. The recruitment program is one of the central components of the CTSI and is being funded by a share of a $40 million grant from the National Institutes of Health that the SMD received two years ago. “ne of the fundamental obstacles to advancing medical research has been the difficulty that many investigators have in recruiting and retaining volunteers in clinical trials” said David Guzick M.

Whiteside awards research grants
Superior Telegram
Luke?s and the University Minnesota Medical School Duluth has announced research grant awardees for 2009. ? Anne Gingery PhD Mechanism of Breast Cancer Protection in Pre-eclampsia. ? Anika Hartz PhD Improving Glioblastoma Chemotherapy through BCRP Downregulation.

Enzo Biochem Names Kevin Krenitsky President of Enzo Clinical Labs
Business Wire (press release)
Enzo’s Life Sciences division develops produces and markets proprietary labeling and detection products for gene sequencing genetic analysis and immunological research among others. Its catalog of over 33000 products serves the molecular biology drug discovery and pathology research markets. The Company’s therapeutic division is in various stages of clinical evaluation of its proprietary immune regulation medicines for uveitis and Crohn’s Disease and conducts pre-clinical research on several candidate compounds aimed at producing new mineral and organic bone including technology that could provide therapy for osteoporosis and fractures among other applications. Enzo’s Clinical Labs division provides routine and esoteric reference laboratory services for physicians in the New York Metropolitan and New Jersey areas. Underpinning the Company’s technology and operations is an extensive intellectual property estate in which Enzo owns or licenses over 230 patents worldwide and has pending applications for over 200 more. For more information visit our website.
Related from Vguideu: USF students aim high for science research and education

» Clinical Research Associate
Hays Pharma
You can find more stories like this at Hayspharma. comFriend email addressSend emailRelated NewsForest and Almirall to conduct further trials ofForest Laboratories and Laboratorios Almirall are to conduct extra clinical trials of its chronic.